6862 Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Environmental 

Health/Agency for Toxic Substances 

and Disease Registry (BSC, NCEH/

ATSDR), Lead Poisoning Prevention 

(LPP) Subcommittee; Notice of 

Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the CDC, National 

Center for Environmental Health/

Agency for Toxic Substances and 

Disease Registry (NCEH/ATSDR) 

announces the following meeting of the 

aforementioned subcommittee: 

Time and Date: 12:00 p.m.–1:45 p.m., 

EST, February 9, 2016. 

Place: This meeting will be held by 

teleconference. To participate in the 

teleconference, please dial 1–877–315– 

6535 Passcode: 383520. 

Status: The meeting is open to the 

public, limited only by the conference 

lines available. The public is welcome 

to participate during the public 

comment period, which is tentatively 

scheduled from 1:30 p.m. to 1:45 p.m. 

This Federal Register Notice is being 

published less than 15 days before the 

meeting because of the urgent nature of 

recent events involving the Flint, 

Michigan water contamination with 

lead. CDC is convening a meeting of the 

Lead Subcommittee of the Board of 

Scientific Counselors to initiate 

discussion of public health measures 

and assessments needed in response to 

this event. 

Purpose: The subcommittee will 

propose strategies and options to the 

Board of Scientific Counselors (BSC) on 

ways to prioritize NCEH/ATSDR’s 

activities, improve health outcomes, and 

address health disparities as it relates to 

lead exposures. The subcommittee will 

deliberate on ways to evaluate lead 

exposure and how to best conduct 

health evaluations through exposure 

and epidemiologic studies. 

Subcommittee proposals on lead 

prevention practices and national lead 

poisoning prevention efforts will be 

provided to the Board of Scientific 

Counselors for deliberation and possible 

adoption as formal recommendations to 

NCEH/ATSDR. 

Matters for Discussion: Agenda items 

will include the following: Blood lead 

testing and health surveillance strategies 

for the residents of Flint, Michigan, 

including methodological approaches 

for conducting retrospective and 

prospective assessments of blood lead 

levels and associated health outcomes. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Sandra Malcom, Committee 

Management Specialist, NCEH/ATSDR, 

4770 Buford Highway, Mail Stop F–45, 

Chamblee, Georgia 30345; telephone 

770/488–0575, Fax: 770/488–3377; 

Email: smalcom@cdc.gov. 

The Director, Management Analysis 

and Services Office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Gary Johnson, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2016–02574 Filed 2–4–16; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–16–0600] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

CDC Model Performance Evaluation 

Program (MPEP) for Mycobacterium 

tuberculosis Drug Susceptibility Testing 

(OMB Control No. 0920–0600, Expires 

5/31/2016)—Extension—National 

Center for HIV/AIDS, Viral Hepatitis, 

STD, and TB Prevention (NCHHSTP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

As part of the continuing effort to 

support domestic public health 

objectives for treatment of tuberculosis 

(TB), prevention of multi-drug 

resistance, and surveillance programs, 

CDC is requesting approval for an 

extension of three years from the Office 

of Management and Budget to continue 

information collection from participants 

in the Model Performance Evaluation 

Program for Mycobacterium 

Tuberculosis Susceptibility Testing. 

Extension of this information collection 

will not require changes in the scope of 

the study, methodology, information 

collection instruments, or burden on the 

respondents. 

While the overall number of cases of 

TB in the U.S. has decreased, rates still 

remain high among foreign-born 

persons, prisoners, homeless 

populations, and individuals infected 

with HIV in major metropolitan areas. 

To reach the goal of eliminating TB, the 

Model Performance Evaluation Program 

for Mycobacterium Tuberculosis Drug 

Susceptibility Testing is used to monitor 

and evaluate performance and practices 

among national laboratories performing 

M. tuberculosis susceptibility testing. 

Participation in this program is one way 

laboratories can ensure high-quality 

laboratory testing, resulting in accurate 

and reliable testing results. 

Extension of this information 

collection provides CDC with an 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 81, No. 26 / Tuesday, February 9, 2016 / Notices 6863 

evaluation program to assess the ability 

of the laboratories to test for drug 

resistant M. tuberculosis strains. 

Laboratories also have a self-assessment 

tool to aid in optimizing their skills in 

susceptibility testing. The information 

obtained from the laboratories on 

susceptibility practices and procedures 

is used to establish variables related to 

good performance, assessing training 

needs, and aid with the development of 

practice standards. 

Participants in this program include 

domestic clinical and public health 

laboratories. Data collection from 

laboratory participants occurs twice per 

year. The data collected in this program 

will include the susceptibility test 

results of primary and secondary drugs, 

drug concentrations, and test methods 

performed by laboratories on a set of 

performance evaluation (PE) samples. 

The PE samples are sent to participants 

twice a year. Participants also report 

demographic data such as laboratory 

type and the number of tests performed 

annually. 

There is no cost to respondents to 

participate other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Domestic Laboratory ....................................... Participant Biosafety Compliance Letter of 

Agreement.

93 2 5/60 

MPEP Mycobacterium tuberculosis Results 

Worksheet.

93 2 30/60 

Online Survey Instrument .............................. 93 2 15/60 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2016–02519 Filed 2–8–16; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC): Notice of Charter 

Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

Advisory Committee to the Director, 

Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS), has been 

renewed for a 2-year period extending 

through February 1, 2018. 

Contact Person For More Information: 

Carmen Villar, M.S.W., Designated 

Federal Officer, Advisory Committee to 

the Director, CDC, 1600 Clifton Road 

NE., Mailstop D14, Atlanta, Georgia 

30333, Telephone 404–639–7000. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2016–02480 Filed 2–8–16; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS Computer Match No. 2016–12; HHS 

Computer Match No. 1604; SSA Computer 

Match No. 1097–1899] 

Privacy Act of 1974 

AGENCY: Department of Health and 

Human Services (HHS), Centers for 

Medicare & Medicaid Services (CMS). 

ACTION: Notice of Computer Matching 

Program (CMP). 

SUMMARY: In accordance with the 

requirements of the Privacy Act of 1974, 

as amended, this notice announces the 

re-establishment of a CMP that CMS 

plans to conduct with the Social 

Security Administration (SSA). 

DATES: Effective Dates: Comments are 

invited on all portions of this notice. 

Public comments are due 30 days after 

publication. The matching program will 

become effective no sooner than 40 days 

after the report of the matching program 

is sent to the Office of Management and 

Budget (OMB) and Congress, or 30 days 

after publication in the Federal 

Register, whichever is later. 

ADDRESSES: The public should send 

comments to: CMS Privacy Officer, 

Division of Security, Privacy Policy & 

Governance, Information Security & 

Privacy Group, Office of Enterprise 

Information, CMS, Room N1–24–08, 

7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. Comments 

received will be available for review at 

this location, by appointment, during 

regular business hours, Monday through 

Friday from 9:00 a.m.–3:00 p.m., Eastern 

Time zone. 

FOR FURTHER INFORMATION CONTACT: 

Elizabeth Kane, Acting Director, 

Verifications Policy & Operations 

Division, Eligibility and Enrollment 

Policy and Operations Group, Center for 

Consumer Information and Insurance 

Oversight, CMS, 7501 Wisconsin 

Avenue, Bethesda, MD 20814, Office 

Phone: (301) 492–4418, Facsimile: (443) 

380–5531, E-Mail: 

Elizabeth.Kane@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Computer Matching and Privacy 

Protection Act of 1988 (Public Law 

(Pub. L.) 100–503), amended the Privacy 

Act (5 U.S.C. 552a) by describing the 

manner in which computer matching 

involving Federal agencies could be 

performed and adding certain 

protections for individuals applying for 

and receiving Federal benefits. Section 

7201 of the Omnibus Budget 

Reconciliation Act of 1990 (Pub. L. 101– 

508) further amended the Privacy Act 

regarding protections for such 

individuals. The Privacy Act, as 

amended, regulates the use of computer 

matching by Federal agencies when 

records in a system of records (SOR) are 

matched with other Federal, state, or 

local government records. It requires 

Federal agencies involved in computer 

matching programs to: 

mstockstill on DSK4VPTVN1PROD with NOTICES